A Wound Care Solution for Better Outcomes
The LumiHeal System utilizes the principles of Fluorescence Biomodulation to manage impaired and damaged skin by delivering fluorescence, at a cellular level, to impact the three (3) critical phases of healing: Inflammation, Proliferation and Remodeling. This active wound care solution delivers high response rates and ignites the onset of wound regression, while providing an excellent safety profile. LumiHeal offers an innovative, pain free, non-invasive, cost-effective alternative to manage wounds, specifically chronic and complex. Despite the many different traditional treatment options available, many patients don’t respond and are subjected to significant discomfort and distress while draining the medical system of global healthcare resources.
The Cutting Edge of Wound Care
LumiHeal is supported by strong scientific evidence, robust clinical data (5 clinical studies completed) and a CE mark in Europe for a variety of wound types including chronic wounds. LumiHeal’s unique mode of action in which fluorescence is the essential part brings much needed innovation to the wound care space, especially given the ballooning costs of stalled and non-responding wounds. Clinicians are seeking solutions that would allow them to optimally treat hard-to-heal patients reducing the burden on global healthcare systems.
Restoring Patient Lives with LumiHeal
Upon LED activation, the Light Absorbing Molecule (LAM) gel generates fluorescence, which penetrates the skin at various depths to deliver high response rates and ignite the fast onset of wound regression, while providing an excellent safety profile. Patients and clinicians report efficacy, ease of use and high levels of satisfaction over current standards of care.
Light Absorbing Molecule (LAM) Gel
Topical product containing proprietary LAM that emit energy in the form of fluorescence, following the absorption of visible light
To be used during the LED activation
Battery operated LED lamp emits monochromatic light within the visible spectrum, calibrated to target LAMs in the proprietary topical product
“LUMIHEAL HAS THE POTENTIAL TO BECOME AN ALTERNATIVE FOR UNMET NEEDS IN THE MANAGEMENT OF CHRONIC ULCERS” – EUREKA CLINICAL INVESTIGATOR
95% of investigators would recommend LumiHeal™ to a colleague, rating it high in effectiveness, safety and ease of use
82% of patients responded positively and could be classified as a responder by week three (3), allowing for anticipatory discontinuation of non-responders
A 50% reduction of in wound surface area was observed after only four (4) weeks of treatment and an 80% reduction was observed after ten (10) weeks
LOW INFECTION RATE
Only 3% of wounds developed an infection during the study period, demonstrating the antibacterial properties of LumiHeal
There were no serious adverse events and three (3) mild adverse events reported during the entirety of the study period
After One (1) Month of LumiHeal
BEFORE: 26 cm2
AFTER: 0 cm2
After Three (3) Months of LumiHeal
BEFORE: 23 cm2
AFTER: 0 cm2
With advancements in portable electronics, the LED Activator is transitioning from a hospital device to a portable, handheld version to address the growing homecare market, affordability and ease of use.
The portable LED Activator is an extremely low costing unit that allows us to reach a wider range of patient in all care settings.
Portable LED Activator
- Light-weight and battery operated
- Compact and easy to transport
- Simple logistics and supply
- Permits versatile coverage for various surface areas
- Available for hospital, clinic and home-care use
Customized LumiHeal Benefits in the Three Critical Phases of Wound Healing
Our solutions start with a need. Current wound care technologies aren’t required to address the different phases of healing and typically focus on one phase per product. We want to impact all three phases of wound healing to bring wounds to a close in a way that makes doctors and patients happy with the overall outcome. Wound healing is a complex, highly regulated process involving three (3) main phases of healing that are critical in maintaining the function of skin: Inflammation, Proliferation and Remodeling.
LumiHeal delivers fluorescence to various layers of the skin, uniquely benefiting all three (3) phases of healing
Dilation of blood vessels occurs, which allows cells to migrate to the affected area(s), specifically white blood cells, antibodies, growth factors, enzymes and nutrients. Signs of oedema, erythema, heat and/or pain can be seen.
Granulation tissue develops following the induction of growth factors and collagen as well as the stimulation of angiogenesis (creation of new blood vessels).
Sometimes known as the Maturation phase, there is remodeling of collagen along with a reduction of blood vessel development. This phase can last a year or longer.
- Promotes an environment that controls bacterial growth
- Anti-inflammatory modulation
- Induction of cell proliferation
- Increase in collagen production
- Stimulation of angiogenesis
- Reorganization of collagen
- Scar maturation
1) Inflammatory Phase
Figure 1. Clinical effects of LumiHeal on bacterial load in human chronic infected lesions show a clear reduction in colony-forming units (∆=7 days) and immediate effects on limiting bacterial growth, measured with Levine swabs and confirmed with MolecuLightTM (allows for the visualization of bacteria). Data on file.
Harmful levels of bacteria are shown in red and the presence of P. aeruginosa is shown in cyan
2) Proliferation Phase
Figure 2. In vitro effects of LumiHeal on the modulation of angiogenesis in wounded diabetic endothelial cells, which line the interior surface of blood vessels. LumiHeal demonstrates the potential to restore endothelial cell function by statistically increasing tube and branching point formation after 24 hours. Data on file.